Deals2 Sept 2025, 02:01 am
Jubilant Pharmova Ltd Completes Sale and Transfer of API Business to Jubilant Biosys Limited
AI Summary
Jubilant Pharmova Ltd has successfully completed the sale and transfer of its Active Pharmaceutical Ingredients (API) Business to Jubilant Biosys Limited (JBL), a wholly-owned subsidiary of the Company. The transaction was carried out in accordance with the terms of the Business Transfer Agreement (BTA) on September 1, 2025. The details of the transaction were previously disclosed in a letter dated June 12, 2025. This intimation is also available on the Company’s website.
Key Highlights
- Jubilant Pharmova Ltd completes the sale and transfer of its API Business to Jubilant Biosys Limited
- The transaction was carried out in accordance with the Business Transfer Agreement (BTA)
- Jubilant Biosys Limited is a wholly-owned subsidiary of the Company
- The sale and transfer was completed on September 1, 2025
- The details of the transaction were previously disclosed in a letter dated June 12, 2025